Thomas Weldon has been a pioneer in health care for three decades and holds 30 patents for medical devices.
Mr. Weldon’s expertise is envisioning new market opportunities, driving businesses to become more successful and getting them to a liquidity event. He has cofounded more than a dozen companies including: Novoste (NOVT), AcuFocus, AqueSys, Liposonix, and Neuronetics (STIM), which in total have created more than $2.7 billion in shareholder value.
In addition, Tom has served on the board of numerous public and private companies, Universities and Foundations including Novoste, Respicardia, Mednova, MyoScience, Liposonics, the Weldon School of Biomedical Engineering at Purdue Iniversity, and Brenau University.
Today, he is the founder, chairman and CEO of Ponce De Leon Health, which focuses on increasing human health span. Rejuvant, the product he helped develop, is available for sale at Rejuvant.com. He also recently served as Chairman and Managing Director of Accuitive Medical Ventures, a venture capital fund with over $230M of AUM.
Prior to his current position, Mr. Weldon was a cofounder, CEO and chairman of Novoste Corporation, where he grew the business from its inception through its IPO with a peak market cap of $1.2B.
Mr. Weldon is a frequently interviewed expert for his industry and has been written about multiple times by Inc. Magazine. In addition, he has spoken for:
• JPMorgan
• Piper Jaffray
• Robertson Stephens
• Cowen & Co
• Several MedTech Strategist Conferences
Tom holds a B.S. in Industrial Engineering from Purdue University and an M.B.A. in Operations and Systems Management from Indiana University. He has received numerous awards including:
• The Distinguished Engineer Alumni Award (Purdue)
• The Outstanding Industrial Engineer Award (Purdue)
• The Burton Morgan Entrepreneurship Award (Indiana University)
• The Junior Achievement IMPACT Award
Tom volunteers his time as an Advisory Board member for the National University of Singapore, the Purdue University Weldon School of Biomedical Engineering, and the Weldon Foundation.
